MPJE AL Practice Test

Under the Alabama State Pharmacy Law, a certificate issued to pharmacist's assistant shall expire on: A. December 31 of even numbered years. B. June 30 of even numbered years. C. May 31 of even numbered years. D. March 31 of even numbered years.

(a) December 31 of even numbered years, [Alabama Pharmacy Practice Act 34-23-50(a)]. The certificate issued to pharmacist's assistant shall expire on December 31 of even numbered years. In order to continue to obtain a certificate as a pharmacist's assistant, a biennial renewal fee in an amount determined by the board shall be paid, but the fee shall not be less than twenty-five dollars ($25) nor more than one hundred fifty dollars ($150).This renewal fee shall be paid to the secretary of the board and shall be due on October 31 and delinquent after December 31 of even-numbered years. The payment of the renewal fee shall entitle the holder thereof to renewal of his or her certificate at the discretion of the board. If any pharmacist's assistant fails to pay a renewal fee on or before the due date, the holder of the certificate may be reinstated as a pharmacist's assistant only upon payment of a penalty of ten dollars ($10) for each lapsed month and all lapsed fees, provided the lapsed time of certification shall not exceed five years, in which case reinstatement may be had only upon satisfactory examination by the board.

How often shall registration to dispense controlled substances by a pharmacy be renewed? A. Every 2 years. B. Every 3 years. C. Every 5 years. D. Every year.

(a) Every 2 years, [Alabama Uniform Controlled Substances Act 680-x-3-.02(c),(d)]. Each pharmacy registration or reregistration to dispense controlled substances listed in Schedule II through V, the registrant shall pay a fee of three hundred dollars ($300) to be renewed in even-numbered years. Each pharmacist registration or reregistration to dispense controlled substances listed in Schedule II through V, the registrant shall pay a fee of one hundred dollars ($100) to be renewed in even-numbered years.

Only physicians specifically certified by the state board of medical examiners may dispense cannabis. This special certification shall be renewed: A. Every three years. B. Every two years. C. Every five years. D. Every year.

(a) Every three years, [Alabama Uniform Controlled Substances Act Section 20-2-116]. Only physicians in the practice of medicine and specifically certified by the state board of medical examiners may dispense cannabis. Each practitioner shall make application for recertification every three years.

A pharmacist has substituted generic Hydroxyzine (Mfg: Teva) for the prescribed brand name Vistaril (Mfg: Pfizer). Which of the following shall be placed on dispensing label? A. Hydroxyzine, (Teva) B. Hydroxyzine, Vistaril (Teva) C. Hydroxyzine, (a generic for Vistaril) D. Vistaril (Pfizer), Hydroxyzine

(a) Hydroxyzine, (Teva), [Alabama Pharmacy Practice Act 34-23-8(3),(5)] Every written prescription issued in this state by a licensed practitioner shall contain two signature lines. Under one signature line shall be printed clearly the words "dispense as written". Under the other signature line shall be printed clearly the words "product selection permitted". The practitioner shall communicate instructions to the pharmacist by signing on the appropriate line. A pharmacist shall record on the prescription form the name and manufacturer or distributor of any drug product dispensed as herein authorized. Unless otherwise indicated by the practitioner, the prescription label on the dispensing container shall indicate the actual drug product dispensed, either the brand name, or if none, the generic name; and the name of the manufacturer or a reasonable abbreviation of the name of the manufacturer.

The Board of Pharmacy authorizes registered technicians in the State of Alabama, in good standing, acting under the direct supervision of an Alabama licensed pharmacist to administer FDA-authorized or FDA-licensed COVID-19 vaccines to persons ages 3 or older. true or false

(a) True, [AL Rule 680-X-2-.03].(1). The Board of Pharmacy authorizes registered technicians in the State of Alabama, in good standing, acting under the direct supervision of an Alabama licensed pharmacist to administer FDA-authorized or FDA-licensed COVID-19 vaccines to persons ages three (3) or older and to administer FDA-authorizedorFDA-licensed ACIP (Advisory Committee on Immunization Practice) recommended vaccines to persons ages three (3) through eighteen (18) according to ACIP's standard immunization schedule, if the requirements listed below are satisfied: a. The vaccine must be ordered by an Alabama licensed pharmacist; b. The Alabama licensed pharmacist must be readily and immediately available to the immunizing registered pharmacy technician; c. The vaccine must be FDA-authorized or FDA-licensed; d. In the case of a COVID-19 vaccine, the vaccination must be ordered and administered according to ACIP's COVID-19 recommendation(s); e. In the case of a childhood vaccine, the vaccination must be ordered and administered according ACIP's standard immunization schedule; f. The registered technician must have a current certificate in basic cardiopulmonary resuscitation; g. The registered pharmacy technician must complete a minimum two (2) hours of ACPE-approved, immunization-related education program to include hands-on injection techniques and identification, recognition, and treatment of emergency reactions to vaccines; h. The Alabama licensed pharmacist must comply with record keeping and reporting requirements; i. The Alabama licensed pharmacist is responsible for complying with requirements related to reporting adverse events.

Each Nonresident Pharmacy that ships, mails, or delivers prescription drugs and/or devices to a patient in the state of Alabama shall designate a resident agent in Alabama for service of process. true or false

(a) True, [Alabama Administrative Code 680-X-2-.07(3)]. Each Nonresident Pharmacy that ships, mails, or delivers prescription drugs and/or devices to a patient in the state of Alabama shall designate a resident agent in Alabama for service of process. Any such Nonresident Pharmacy that does not designate a registered agent and that ship, mails or delivers prescription drugs and/or devices in the state of Alabama shall appoint the Secretary of State to be its true and lawful attorney to serve all legal process. A copy of any such service of process shall be mailed to the Nonresident Pharmacy by the complaining party by certified mail, return receipt requested, postage prepaid, at the address of such Nonresident Pharmacy as designated on the pharmacy's application for registration in this state.

A CPA must include: [Select ALL That Apply]. A. Specific pharmacist prescribing authority pursuant to the agreement. B. Detailed practice protocols. C. Description of risk management activities. D. Description of outcome measurements.

(a,b,c,d), [AL Rule 680-X-2-.44(4)(b) and AL Law 34-23-77 Collaborative Practice]. A CPA must include: 1. Health, wellness, preventative and disease state(s) being managed, with each disease state identified as either primary or co-morbid; 2. Specific pharmacist prescribing authority pursuant to the agreement; 3. Detailed practice protocols; 4. Description of risk management activities; 5. Documentation of any initiation, modification, or discontinuation of a patient's medication in the patient's medical record in the custody of the collaborating physician; 6. Description of outcome measurements; 7. Protocol to dictate the method, manner and time for communication of the needs of patients; 8. Detailed process for continuation of the patient's drug therapy should the CPA be terminated or not renewed. A collaborative practice agreement must be submitted to the Alabama Board of Pharmacy and the Alabama Board of Medical Examiners within 10 days after the agreement is signed by both parties. A copy of the collaborative practice agreement and any amendment thereto shall be submitted to each respective board within 10 days after the agreement is signed by both parties. The Alabama Board of Pharmacy and the Alabama Board of Medical Examiners must approve the CPA prior to the initiation of the agreement.

In any computerized system employed by a user pharmacy, the central record keeping location must be capable of sending the printout of refill data to the pharmacy within _______ business days. A. 1 B. 2 C. 3 D. 4

(b) 2 business days, [Alabama Administrative Code 680-x-2-.15(1)(d)(e)]. The computerized system shall have the capability producing a printout of any refill data which the user pharmacy is responsible for maintaining under the Alabama Controlled Substances Act and its implementing regulations. For example, this would include a refill-by-refill audit trail for any specified strength and dosage form of any controlled substance (by either brand, generic name, or both). Such a printout must include the name of the prescribing practitioner, name and address of the patient, quantity dispensed on each refill, date of dispensing on each refill, name or identification code of the dispensing pharmacist, and the number of the original prescription order. In any computerized system employed by a user pharmacy, the central record keeping location must be capable of sending the above printout data to the pharmacy within two business days.

How long must a pharmacist be licensed before he/she can become a preceptor? A. 1 year B. 2 years C. 3 years D. 4 years

(b) 2 years, [680-X-2-.09] In order to be approved as a preceptor, a Pharmacist must have been licensed to practice pharmacy for a minimum of two (2) years. All Pharmacists who have been approved by the Alabama State Board of Pharmacy as Preceptors must attend a training seminar for preceptors at least once every three years. Such training seminar shall have prior approval of the Board.

In Alabama, inventory records must be maintained for a period of at least: A. 1 year B. 2 years C. 3 years D. 4 years

(b) 2 years, [Alabama Controlled Substances 20-2-56 and 21CFR1304.04(a)]. Persons registered to manufacture, distribute or dispense controlled substances shall keep records and maintain inventories in conformance with the record keeping and inventory requirements of federal law. Federal Law: Inventory records must be maintained for a period of at least two years from the date of such inventory or record.

The prescription area of a retail pharmacy in Alabama must be minimum of: A. 150 square feet. B. 240 square feet. C. 350 square feet. D. 500 square feet.

(b) 240 square feet, [Alabama Pharmacy Practice Act 34-23-71]. Any new pharmacy or any existing pharmacy which is to be remodeled or which is to be moved to a new location other than a hospital pharmacy must comply with the following requirements for the prescription room area: 1. That portion or part of the entire licensed pharmacy which is to be occupied by the prescription compounding or dispensing department, including that portion or part thereof utilized for the sale of restricted drugs, shall be not less than 240 square feet. 2. The surface of the prescription compounding counter shall be not less than 24 inches in width and not less than 16 square feet of unobstructed working space for one pharmacist and not less than 24 square feet of total working space where two or more pharmacists are to be on duty at any one time. 3. The aisle space or floor area to be occupied by a dispensing pharmacist shall extend the full length of the prescription compounding counter, and it shall be clear and unobstructed for a minimum distance of 36 inches from the working side of the prescription compounding counter.

An emergency oral prescription for Schedule II controlled drugs must be mailed to dispensing pharmacy by an authorized prescriber within: A. 48 hours after an oral authorization. B. 7 days after an oral authorization. C. 10 days after an oral authorization. D. 72 hours after an oral authorization.

(b) 7 days after an oral authorization, [Alabama Uniform Controlled Substances Act 20-2-58(g)]. In Section X of the DEA Pharmacist' Manual, the "emergency" is defined to mean that the immediate administration is necessary for proper treatment and that no alternative (including use of a non-Schedule II drug) is available. In an emergency situation, a pharmacist may dispense a Schedule II controlled substance for a resident of a long-term care facility, a patient receiving hospice services, or a patient receiving home health care services pursuant to an emergency oral prescription transmitted by the practitioner to the dispensing pharmacy. The quantity dispensed pursuant to an emergency oral prescription shall be limited to the amount adequate to treat the patient during the emergency period not to exceed 72 hours. The practitioner, within seven days of the emergency oral prescription, shall provide the dispensing pharmacy with a written prescription for the quantity prescribed.

According to Alabama State Pharmacy Law, a pharmacist whose license has been denied, revoked, suspended, or restricted for disciplinary purposes shall be eligible to be registered as a pharmacy technician. True or False

(b) False, [Alabama Administrative Code 680-X-2-.14 (7)]. According to Alabama State Pharmacy Law, a pharmacist whose license has been denied, revoked, suspended, or restricted for disciplinary purposes shall NOT be eligible to be registered as a pharmacy technician.

All pharmacist consultants to long term care facilities are required to successfully complete a training seminar for consultants of not less than six (6) live integrated hours that have been previously approved by the Board each renewal cycle. true or false

(b) False, [Alabama Administrative Code 680-x-2-.08(a)(5)]. Under Alabama State Pharmacy Law, All pharmacist consultants to long term care facilities, assisted living facilities, nursing homes, domiciliaries, homes of the aged, government agencies, and all other pharmaceutical consultants are required to successfully complete not less than eight (8) live hours that have been previously approved by the Board each renewal cycle. Any pharmacist consultant to long term care facilities, nursing homes, domiciliaries, homes of the aged, government agencies, and any other pharmaceutical consultation practice shall register initially and biennially which shall expire on December 31 of even-numbered years in each instance such practice with the Alabama State Board of Pharmacy on forms provided by the Board.

The supervising pharmacist shall be responsible for no more than two pharmacies at any given time. true or false

(b) False, [Alabama Administrative Code 680-x-2-.12(1)]. Every Pharmacy shall be under direct supervision and control of a registered Pharmacist who shall be designated the supervising pharmacist. The supervising pharmacist shall be responsible for no more than one Pharmacy and in which Pharmacy he/she practices. The supervising pharmacist shall be on duty a minimum of 50% of the hours the pharmacy is in operation or at least thirty (30) hours per week, whichever is less.

According to Alabama State Pharmacy Law, having two technicians on duty, one of which shall be certified through the Pharmacy Technician Certification Board (PTCB), is sufficient in the prescription area of a retail pharmacy or an institutional pharmacy for each full-time licensed pharmacist on duty. True or False

(b) False, [Alabama Administrative Code 680-x-2-.14(3) and Alabama Pharmacy Practice Act 34-23-151(b)]. According to Alabama State Pharmacy Law, three (3) technicians, one of which shall be certified through the Pharmacy Technician Certification Board (PTCB) or the Institute for the Certification of Pharmacy Technicians (ICPT), on duty are sufficient in the prescription area of a retail pharmacy or an institutional pharmacy for each full time licensed pharmacist on duty. If no technicians are certified then the ratio is two (2) to one (1). While compounding, there shall be no more than three technicians per pharmacist.

If a pharmacist accepts an oral prescription of any nature, the pharmacist may directly enter the information into an electronic system. This process of keying the information immediately into a pharmacy system without first reduced to writing on a physical paper will be considered "illegal practice" by the Alabama Board of Pharmacy. true or false

(b) False, [Alabama Board Policy 18-011 and 19-002].Board Policy 18-011: Refill Authorizations Reduced to Writing: If the pharmacy uses a fax refill authorization form and puts all the required information on the prescription, whether it's handwritten or computer new prescription number, it is considered by the Alabama Board of Pharmacy to be reduced to writing. Board Policy 19-002: Prescription Acceptance Reduced to Writing If the pharmacist or registered intern accepts an oral prescription of any nature, the pharmacist or registered intern may directly enter the information into an electronic system. This process of keying the information immediately into a pharmacy system will be considered "reduced to writing" by the Alabama Board of Pharmacy.

In Alabama, no sale of a poison shall be made or delivered to any minor under 18 years of age. True or False

(b) False, [Alabama Pharmacy Practice Act 34-23-70(d)]. The sale of poisons is restricted to the immediate supervision of a licensed pharmacist, and such poison shall not be displayed in a pharmacy in such a manner that a customer may obtain possession of such poisons when standing in an area allocated for customer use. No sale of a poison shall be made or delivered to any minor less than 12 years of age or to any person known to be of unsound mind or under the influence of alcohol.

According to Alabama State Pharmacy Law, controlled substances administered to patients by injection during the course of treatment are required to be reported to a controlled substances prescription database program. true or false

(b) False, [Alabama Uniform Controlled Substances Act 20-2-212 and 20-2-213 (a),(b) and (d)]. Controlled substances administered to patients by injection, topical application, suppository administration, or oral administration during the course of treatment are EXCLUDED from the reporting requirement.

Every pharmacy or manufacturer/distributor of prescription legend drugs including drugs that are controlled substances shall immediately notify the Board any time there is a termination of that operation and shall surrender all licenses and permits to the Board within 30 days of the termination. true or false

(b) False, [Alabama Uniform Controlled Substances Act 680-x-3-.06(1)-to-(3)]. 1. Every pharmacy or manufacturer/distributor of prescription legend drugs including drugs that are controlled substances shall immediately notify the Board any time there is a termination of that operation and shall surrender all licenses and permits to the Board within 10 (Not 30) days of the termination. 2. Within ten (10) days of termination of operation of any pharmacy, manufacturer or distributor registered with the Alabama State Board of Pharmacy, an inventory of all controlled substances on hand at the time of termination of operation shall be furnished the State Board of Pharmacy. Final disposition of all controlled substances on hand at the time of termination shall be reported to the Board as it may occur. 3. Manufacturers and distributors of controlled substances located outside of this state and holding licenses and permits to distribute controlled substances within the state shall not be required to furnish inventory and disposition of controlled substances as stated. 4. The next of kin of any deceased licensed pharmacist owner of a Pharmacy shall have a period of thirty (30) days within which to comply with the provisions of this rule during which time no prescriptions shall be filled unless a licensed pharmacist is on duty.

An oral prescription for schedule II controlled prescription drug by a licensed practitioner is allowed in his usual course of practice. true or false

(b) False, [http://www.albop.com/FAQ.aspx See FAQ PRESCRIPTIONS: CONTROLLED SUBSTANCES Q.4.]. Only in an emergency situation for a resident of a long-term care facility, a patient receiving hospice services, or a patient receiving home healthcare services is an oral order for a schedule II controlled substance permitted. The physician must provide a hard copy of the prescription within 7 days. If the prescriber does not provide said hard copy, the pharmacist is responsible for contacting the DEA.

In Alabama, the quantity of controlled substances dispensed shall not be exceeded more than 30-day supply. True or False

(b) False, [https://www.albop.com/FAQ.aspx Prescriptions Controlled Substances Q.3] While some states and many insurance carriers limit the quantity of controlled substances dispensed to a 30-day supply, there are no expressed federal limits with respect to the quantities of drugs dispensed via a prescription. However, the amount dispensed must be consistent with the requirement that a prescription for a controlled substance be issued only for a legitimate medical purpose by a practitioner acting in the usual course of professional practice.

A pharmacy may provide a partially or fully pre-populated form for the prescribing practitioner for controlled substance prescriptions. true or false

(b) False, [https://www.albop.com/FAQ.aspx Prescriptions_Controlled Substances Q.27]. The Drug Enforcement Administration (DEA) ruling relates to faxing refill requests and indicates that pharmacies "may not provide a partially or fully pre-populated form for the prescribing practitioner for controlled substance prescriptions. "This applies to pre-printed forms used by both retail and long-term care pharmacies to remind prescribers that a patient is out of refills on certain controlled substance prescriptions. DEA has stated that a pharmacist cannot send a reminder letter that provides a partially or fully pre-populated form for the prescriber or prepare a prescription for signature because the pharmacist is not an agent of the prescriber. Any reminder letters cannot look like a prescription. Pharmacies need to work with their software vendor to ensure that these forms are in full compliance with DEA rules. **Please Note this rule DOES NOT APPLY to non-controlled substance prescriptions.**

What are training requirements to become a licensed nuclear pharmacist? I. 200 hours of classroom and laboratory training. II. 500 hours of training and experience in the handling of unsealed radioactive material III. Minimum 8 hours of continuing education in handling radioactive materials every renewal period. A. I only B. I and II only C. II and III only D. All

(b) I and II are required, [Alabama Administrative Code 680-x-2-.20(4), and (7)(a),(b)]. 1. A licensed pharmacist seeking to practice nuclear pharmacy in this state, shall submit to the Board of Pharmacy, a certificate of training and a course outline from an accredited college of pharmacy, or other program recognized by the State of Alabama Department of Public Health, Radiological Health Branch and the Alabama Board of Pharmacy, and a certificate of such training which provides a minimum of 200 clock hours of formal didactic training. 2. The minimum on-the-job training which shall be included in a radiopharmacy internship is five hundred (500) hours of training and experience in the handling of unsealed radioactive material under the supervision of a licensed nuclear pharmacist. 3. Applications and re-certification with the Board is required biennially which shall expire on December 31 of even-numbered years on forms provided by the Board. Satisfactory completion of no less than two (2) hours of continuing education prior to re-certification earned in the previous calendar year related to nuclear pharmacy shall be required.

Which of the following information is/are TRUE under the Alabama State Pharmacy Law? I. The permit holder is responsible and accountable for assuring the supervising pharmacist is working the designated hours set by the Board and for the renewal of the pharmacy permit. II. If the permit holder is unable to maintain a designated supervising pharmacist, the permit holder shall notify the Board within 10 days with an action plan to designate another pharmacist as supervising pharmacist. III. A permit holder without a designated supervising pharmacist after the 180 day period may be asked to close until such time as a designated supervising pharmacist can assume the duties. A. I only B. I and II only C. II and III only D. All

(b) I and II are true, [Alabama Administrative Code 680-X-2-.12 (6) to (9)]. The permit holder is responsible and accountable for assuring the supervising pharmacist is working the designated hours set by the Board and for the renewal of the pharmacy permit. If the permit holder is unable to maintain a designated supervising pharmacist, the permit holder shall notify the Board within ten (10) days with an action plan to designate another pharmacist as supervising pharmacist. This plan can be for a period not to exceed ninety (90) days before the permit is in violation for operating without a supervising pharmacist. A permit holder without a designated supervising pharmacist after the ninety (90) (not 180 day) day period may be asked to close until such time as a designated supervising pharmacist can assume the duties. If the actions of the permit holder have deemed to contribute to or cause a violation of any provision of this section, the Board may hold the permit holder responsible and/or absolve the supervising pharmacist from the responsibility of that action. In the event of a temporary absence by supervising pharmacist of greater than 30 days, the permit holder shall designate a temporary supervising pharmacist with notification to the Board of the name of the temporary supervising pharmacist and the period of time during which he/she shall act as such. The permit holder must notify the Board of the assignment of the temporary supervising pharmacist prior to the time the temporary supervising pharmacist begins to act as such. The permit holder will inform the board of the date of the original supervising pharmacist's return from his/her absence.

Which of the following information regarding Central Filling is/are TRUE? I. A retail pharmacy may outsource a prescription drug order filling to another retail pharmacy provided the pharmacies have the same owner. II. No central fill pharmacy operating within Alabama shall accept for refund purposes or otherwise any unused portion of any filled prescription. III. Schedule II and III drugs may not be centrally filled. A. I only B. I and II only C. II and III only D. All

(b) I and II are true, [Alabama Administrative Code 680-x-2-.30(3)(a)]. A retail pharmacy may outsource a prescription drug order filling to another retail pharmacy provided the pharmacies: (i). Have the same owner; or (ii). Have entered into a written contract or agreement which outlines the services to be provided and the responsibilities and accountabilities of each pharmacy in compliance with federal and state laws and regulations; and (iii). Share a common electronic file or have appropriate technology or interface to allow access to sufficient information necessary or required to fill or process a prescription drug order. 2. Any filled prescription, which was not picked up, must be put into the dispensing pharmacy' inventory. 3. No licensed pharmacist or central fill pharmacy operating within this state shall accept for refund purposes or otherwise any unused portion of any filled prescription. 4. Schedule I and II drugs may not be centrally filled.

Which of the following statements are TRUE about the OTC sale of pseudoephedrine in the State of Alabama? I. No person shall deliver, sell, or purchase products sold over-the-counter that contain a combined total of more than 3.6 grams per calendar day of pseudoephedrine. II. The purchaser of pseudoephedrine shall be at least 18 years of age. III. No person shall deliver, sell, or purchase products sold over-the-counter that contain a combined total of more than 9 grams within 30 days of pseudoephedrine. A. I only B. I and II only C. II and III only D. All

(b) I and II are true, [Alabama Uniform Controlled Substances Act 20-2-190(c)(2),(3),(4)]. (1). Products whose sole active ingredient is ephedrine or pseudoephedrine in strength of 30 mg or more per tablet cannot be offered for retail sale loose in bottles, but must be sold only in blister packages. (2). No person shall deliver, sell, or purchase products sold over-the-counter that contain a combined total of more than 3.6 grams per calendar day or more than 7.5 grams within 30 days, of ephedrine base or pseudoephedrine base. (3). The purchaser of OTC pseudoephedrine of ephedrine shall be at least 18 years of age.

Which of the following Statements are TRUE about Stat Cabinets under Alabama State Pharmacy Law? I. Each institutional facility may maintain one "Stat" cabinet/enclosure for the purpose of keeping a minimum amount of stock medications that may be needed quickly or after regular duty hours. II. The pharmacist shall inspect the "Stat" cabinet at least monthly, replacing outdated drugs and performing a reconciliation of its prior usage. III. The number of drugs provided by a pharmacy to keep in drug cabinets at a long-term care facility shall be limited to fifty. A. I only B. I and II only C. III only D. All

(b) I and II are ture, [Alabama Uniform Controlled Substances 680-x-2-.18(4)(e)]. For an institutional Facility that does not have an institutional pharmacy, Drugs may be stored in a cabinet/enclosure to which only authorized personnel may obtain access by key, combination, or access code and which is sufficiently secure to deny access to unauthorized persons, provided, however, such cabinet/enclosure meet the following requirements: 1. Definition: A Stat Cabinet consists of non-controlled drugs needed to effectively manage a patient' drug regimen when these drugs are not available from any other authorized source in sufficient time to prevent risk of harm to a patient by delay resulting from attaining such drugs from other sources. 2. Each facility may maintain one "Stat" cabinet/enclosure for the purpose of keeping a minimum amount of stock medications that may be needed quickly or after regular duty hours. If a facility wants more than one "Stat" cabinet/enclosure, it must be approved by the Alabama State Board of Health and the Alabama State Board of Pharmacy. 3. All medications shall be packaged in an appropriate manner in the "stat" cabinet based on the established needs of the facility. Need for such medications shall be reviewed by the pharmacist annually. 4. There must be a list of contents, approved by the appropriate committee and a pharmacist, giving the name and strength of the drug and the quantity of each. Contents of the "Stat" cabinet shall be properly labeled with name, strength and expiration date. 5. There shall be records available to show amount received, name of resident and amount used, prescribing physician, time of administration, name of individual removing and using the medication and the balance on hand. 6. There shall be written procedures for utilization of the "Stat" cabinet with provisions for prompt replacement of used items. 7. The pharmacist shall inspect the "Stat" cabinet at least monthly, replacing outdated drugs and performing a reconciliation of its prior usage.

Which of the following is/are required to prescribe schedule III, IV or V controlled substances by a physician assistant? I. QACSC certificate II. DEA registration number III. Alabama State Pharmacy Board Authorizing letter A. I only B. I and II only C. II and III only D. All

(b) I and II only**, [Alabama Pharmacy Practice Act 20-2-63]. (a). Upon receipt of a Qualified Alabama Controlled Substances Registration Certificate and a valid registration number issued by the United States Drug Enforcement Administration, an assistant to physician may prescribe, administer, authorize for administration, or dispense only those controlled substances listed in Schedules III, IV, and V. (b). An assistant to physician shall not utilize his or her QACSC for the purchasing, obtaining, maintaining, or ordering of any stock supply or inventory of any controlled substance in any form. **Conflict information: As of February 2, 2020, assistant to physicians are only allowed for prescribing, administering and dispensing schedule III, IV or V controlled drugs. However, according to https://www.deadiversion.usdoj.gov/drugreg/practioners/mlp_by_state.pdf, physician assistants in Alabama are allowed to prescribe, administer or dispense schedule II, III, IV or V controlled drugs.

What qualifications are required to become a collaborating pharmacist? I. A current, unrestricted license to practice pharmacy in the state of Alabama. II. Adequate training and/or experience for the execution of the CPA. III. Minimum 10 hours of continuing education at every license renewal period in area where collaborating pharmacist principally practices. A. I only B. I and II only C. II and III only D. All

(b) I and II only, [AL Rule 680-X-2-.44. Collaborative Practice]. "Collaborative Drug Therapy Management" or "CDTM" means the initiating, monitoring, modifying, and discontinuing of a patient's drug therapy by an authorized pharmacist in accordance with a collaborative practice agreement with a physician. "Collaborative Practice Agreement" or "CPA" means a written and signed agreement between a pharmacist with training and experience relevant to the scope of collaborative practice and a collaborating physician that defines the collaborative practice in which the pharmacist and physician propose to practice. "Collaborating Physician" means a physician who holds an active license to practice in the State of Alabama. A collaborating physician in a CPA may only delegate to a collaborating pharmacist (or a licensed pharmacist substituting for the collaborating pharmacist if unavailable) pursuant to the written agreement and protocols with the pharmacist. "Collaborating Pharmacist" means a pharmacist who holds a license to practice in the State of Alabama. A collaborating pharmacist in a CPA may perform CDTM with a collaborating physician (or a licensed physician substituting for the collaborating physician if unavailable) pursuant to the written agreement and protocols with the physician. The collaborating pharmacist shall have: 1. A current, unrestricted license to practice pharmacy in the state of Alabama; 2. Paid all collaborative practice fees due to the Alabama Board of Pharmacy; 3. Adequate training and/or experience for the execution of the CPA as determined by the Board.

According to Alabama State Pharmacy Law, a hard-copy printout of each day' controlled substance prescription order refill data must be provided to each pharmacy using such a computerized system within seventy-two hours of the date on which the refill was dispensed. true or false

(a) True, [Alabama Administrative Code 680-x-2-.15(1)(c),(d),(e)]. The computerized system shall provide a hard-copy printout of each day' controlled substance prescription order refill data, and that printout shall be verified, dated, and signed. The individual pharmacist must verify that the data indicated is correct and then sign this document in the same manner as he or she would sign a legal document. This printout of the day' controlled substance prescription order refill data must be provided to each pharmacy using such a computerized system within seventy-two hours of the date on which the refill was dispensed; or in lieu of such a printout, the pharmacy shall maintain a bound log book, or separate file, in which each individual pharmacist involved in such dispensing shall sign a Statement each day in the same manner as he or she would sign a legal document, attesting to the fact that the refill information entered into the computer that day has been reviewed by him or her and is correct as shown. In any computerized system employed by a user pharmacy, the central record keeping location must be capable of sending the printout to the pharmacy within two business days; and if an Inspector of the Alabama State Board of Pharmacy or DEA special agent or compliance investigator request a copy of such printout from the user pharmacy. In addition to the controlled substances printout referred to above, a printout shall be obtained at least weekly of all new and refill prescription activity of the pharmacy for this period. All documentation required under this rule shall be kept in a separate binder and retained for two years.

According to Alabama State Pharmacy Law, a prescription for Duragesic cannot be filled by using a Central Filling Pharmacy. true or false

(a) True, [Alabama Administrative Code 680-x-2-.30(3)(a)(5)]. According to Alabama State Pharmacy Law, Schedule I and II controlled drugs cannot be centrally filled. Duragesic (Fentanyl) is classified as a Schedule II controlled substance. Central Prescription Filling is defined as the filling of a new or refilling of a prescription drug order by one pharmacy licensed by the Alabama State Board of Pharmacy at the request of another pharmacy licensed by the Alabama State Board of Pharmacy for delivery to the patient or patient' agent, pursuant to the lawful order of a practitioner.

Each pharmacist licensed by the board shall notify the board in writing within 10 days on change of employment. True or False

(a) True, [Alabama Pharmacy Practice Act 34-23-10]. According to Alabama State Pharmacy Law, each pharmacist licensed by the board shall notify the board in writing within 10 days on change of employment. The notice shall contain his name, license number, the name of the pharmacy where formerly employed and the name of the pharmacy where currently employed.

Under an Alabama State Pharmacy Law, a pharmacy technician shall complete three hours of continuing education annually, of which one hour shall be live presentation. Ture or False

(a) True, [Alabama Pharmacy Practice Act 34-23-131(d) and Alabama Administrative Code 680-X-2-.37(1)]. Under Alabama State Pharmacy Law, a pharmacy technician shall complete three hours of continuing education annually, or six hours biennially, of which one hour shall be live presentation. (a). A pharmacy technician shall not perform pharmacy functions or be present in the prescription department of a pharmacy unless he or she is under the direct supervision of a licensed pharmacist. A pharmacy technician shall not perform pharmacy functions or be present in the prescription department of a pharmacy unless he or she is registered by the board. (b). When supervision is required, a licensed pharmacist shall be jointly responsible and liable for the actions of a pharmacy technician. (c). A pharmacy technician shall register and pay a fee as determined by the board before performing any pharmacy functions. The board shall develop rules and regulations relating to the registration of all pharmacy technicians. The registration of a pharmacy technician shall be renewable biennially in odd numbered years upon payment of the required fee. (d). In addition to any other registration requirements, a pharmacy technician shall complete three hours of continuing education annually or 6 hours per license renewal, of which one hour (2 hours per license renewal) shall be live presentation. (e). It is the responsibility of each pharmacy technician to maintain and compile accurate records relating to all continuing education courses or activities they have attended and completed. It shall be the responsibility of each pharmacy technician to maintain above described documentation and information pertaining to each year for a period of two (2) years and this information shall be submitted to the Board of Pharmacy within thirty (30) calendar days after a request for the same by the Board.

Any person who shall practice pharmacy in this state without having first obtained from the board a license shall be guilty of a misdemeanor and, upon conviction, shall be punished by fine of not more than $1,000.00 for each offense. True or False

(a) True, [Alabama Pharmacy Practice Act 34-23-13]. Any person who shall practice pharmacy in this state without having first obtained from the board a license, or who permits prescriptions to be compounded and/or dispensed by unauthorized persons; or who violates any of the provisions of this chapter; or who willfully violates any published rule or regulation of the board; or who does any act described in this chapter as unlawful, the penalty for which is not herein specifically provided, shall be guilty of a misdemeanor and, upon conviction, shall be punished by fine of not more than $1,000.00 for each offense, to be fixed by the court trying said case, and in addition thereto may be, in the discretion of the court trying said case, sentenced to hard labor for the county for a period not to exceed 12 months.

Under an Alabama State Pharmacy Law, a pharmacy may prepare a compounded drug product to be sold over the counter without a prescription order. true or false

(a) True, [Alabama Pharmacy Practice Act 34-23-159]. A pharmacy may prepare a compounded drug product to be sold over the counter without a prescription order. The product shall not contain an ingredient which exceeds recommended strengths and doses for over the counter drugs. The finished product shall not be one for which a prescription is required. It shall be properly labeled with the product' name, directions for use, list of active ingredients, and any necessary warnings. A compounded product shall be sold directly to the consumer after professional interaction or consultation between the pharmacist and the consumer. The product may be prepared in advance in reasonable amounts in anticipation of estimated needs. The product shall be stored within the prescription department. The product may not be sold in bulk to other pharmacies or vendors for resale.

No licensed pharmacist or pharmacy operating within this state shall accept for refund purposes or otherwise any unused portion of any dispensed prescription. true or false

(a) True, [Alabama Pharmacy Practice Act 34-23-70].(c) (1). No licensed pharmacist or pharmacy operating within this state shall accept for refund purposes or otherwise any unused portion of any dispensed prescription. (2). The prohibition in subdivision (1) shall not apply to any unused or expired dispensed medication returned solely for the purpose of destruction in compliance with applicable law or rules of the board.

A pharmacy with a current retail pharmacy permit may repackage, re-label, or store any non-controlled legend drug for a patient residing in a residential care facility which does not have a pharmacy located on the premises. true or false

(a) True, [Alabama Pharmacy Practice Act 34-23-76]. The Board of Pharmacy may establish by rule protocols allowing a pharmacy in possession of a current retail pharmacy permit to repackage, re-label, and store any non-controlled legend drug for a patient residing in a residential care facility which does not have a pharmacy located on the premises. (b). For purposes of this section, a residential care facility means any of the following: (1). A convalescent home. (2). A nursing home. (3). An extended care facility. (4). A mental health or psychiatric facility. (5). A rehabilitation facility. (6). A developmental disability center. (7). An assisted living facility. (8). A speciality (sic) care assisted living facility.

A pharmacist who is the general owner or operator of an establishment where ephedrine or pseudoephedrine products are available for sale shall not be penalized for conduct of an employee if the retailer documents that an employee training program was conducted by the ADATF. true or false

(a) True, [Alabama Uniform Controlled Substances Act 20-2-190(c)(8)]. A pharmacist who is the general owner or operator of an establishment where ephedrine or pseudoephedrine products are available for sale shall not be penalized pursuant to this section for conduct of an employee if the retailer documents that an employee training program was conducted by or approved by the Alabama Drug Abuse Task Force (ADATF). The Alabama Board of Pharmacy shall develop or approve all training programs and submit such programs to the ADATF for approval. The ADATF must review any training programs submitted by the Alabama Board of Pharmacy at its next subsequent called or scheduled public meeting and within 7 days, report its decision in writing to the Alabama Board of Pharmacy.

A licensed physician approved by the department who has authority to prescribe, dispense, or administer controlled substances may designate up to two employees who may access the controlled substance monitoring database on the physician's behalf. true or false

(a) True, [Alabama Uniform Controlled Substances Act 20-2-214(3)]. The following persons or entities shall be permitted access to the information in the controlled substances database, subject to the limitations indicated below: 1. Authorized representatives of the certifying boards. 2. A licensed practitioner approved by the department who has authority to prescribe, dispense, or administer controlled substances. 3. A licensed physician approved by the department who has authority to prescribe, dispense, or administer controlled substances may designate up to two employees who may access the database on the physician's behalf. 4. A licensed certified registered nurse practitioner or a licensed certified nurse midwife approved by the department who is authorized to prescribe, administer, or dispense pursuant to a Qualified Alabama Controlled Substances Registration Certificate. 5. A licensed assistant to physician approved by the department who is authorized to prescribe, administer, or dispense pursuant to a Qualified Alabama Controlled Substances Registration Certificate 6. A licensed pharmacist approved by the department, provided, however, that such access is limited to information related to the patient or prescribing practitioner designated on a controlled substance prescription that a pharmacists has been asked to fill. 7. State and local law enforcement authorities and federal law enforcement authorities. 8. Employees of the department and consultants engaged by the department for operational and review purposes. 9. Authorized representatives of the Alabama Medicaid Agency; provided, however, that access shall be limited to inquiries concerning possible misuse or abuse of controlled substances by Medicaid recipients.

A prescription for a Schedule II controlled substance may be transmitted by the agent of the practitioner to a pharmacy via facsimile equipment. True or False

(a) True, [Alabama Uniform Controlled Substances Act 20-2-58(a)]. A prescription for a Schedule II controlled substance may be transmitted by the practitioner or the agent of the practitioner to a pharmacy via facsimile equipment provided the original written, signed prescription is presented to the pharmacist for review prior to the actual dispensing of the controlled substance.

According to Alabama State Pharmacy Law, the prescription record should be kept for: A. Two years from the date of dispensing. B. Five years from the date of dispensing. C. Three years from the date of dispensing. D. A year from the date of dispensing.

(a) Two years from the date of dispensing, [Alabama Pharmacy Practice Act 34-23-70(k)]. A prescription file or files shall be kept by every pharmacy for a period of not less than two years in which the original of every prescription compounded or dispensed shall be filed in the order of compounding with number and date of dispensing placed on each prescription. Each pharmacy shall produce any prescription file whenever legally required to do so. Such prescription file shall at all times be open for inspection by: a). the prescriber, b). the board of pharmacy or its inspectors.

Can a prescription for a Controlled Substance III to IV with 5 refills be filled more than 5 times, if the patient only receives partial fillings? A. Yes B. No

(a) Yes, [https://www.albop.com/FAQ.aspx Q.9 PRESCRIPTIONS: CONTROLLED SUBSTANCES]. Partial fills of schedules III and IV controlled substance prescriptions are permissible under federal regulations provided that each partial filling is dispensed and recorded in the same manner as a refilling (i.e., date refilled, amount dispensed, initials of dispensing pharmacist, etc.), the total quantity dispensed in all partial fillings does not exceed the total quantity prescribed, and no dispensing occurs after six months past the date of issue.

In Alabama, the inventory of controlled substances should be done every: A. Year B. Two years C. Three years D. Five years

(a) year, [Alabama Uniform Controlled Substances 680-x-3-.08]. In Alabama, the inventory of controlled substances should be done every year on January 15th or the alternative fixed date approved by the Board of each year following the date the initial inventory was taken. The annual inventory may be taken on any fixed date which does not vary by more than six (6) months from the annual date that would otherwise apply. If the registrant elects to take the annual inventory on another fixed date, he must first petition the Board for approval of the alternative fixed date on which the annual inventory will be taken. The inventory by a pharmacy must be taken either as of the opening of business or as of the closing of business. The pharmacy shall indicate on the inventory records whether the inventory was taken as of the opening of business or as of the close of business, the date the inventory was taken, followed by the signature of the person responsible for taking the inventory. In determining the number of units of each finished form of a controlled substance in a commercial container which has been opened, the pharmacy shall do as follows: (a) If the substance is listed in Schedule II, an exact count or measure of the contents shall be made. (b) If the substance is listed in Schedule III, IV or V, an estimated count or measure may be made of the contents unless the container holds more than 1000 tablets or capsules in which case an exact count of the contents must be made.

Which of the following Statements are TRUE about emergency kits under an Alabama State Pharmacy Law? I. The contents of the emergency kit shall consist of those drugs needed to effectively manage a critical care incident or need of a patient. II. Drugs shall be removed from emergency kits only pursuant to a valid written order of an authorized practitioner. III. Whenever an emergency kit is opened, the supplying pharmacist shall be notified and the pharmacist shall stock and reseal the kit within a reasonable time but not more than 7 days later. A. I only B. I and II only C. II and III only D. All

(b) I and II only, [Alabama Administer Code 680-x-2-.18(4)(d)]. For an Institutional Facility that does not have an Institutional Pharmacy, Drugs may be provided for use by authorized personnel by emergency kits located at such Facility, provided, however, such kits meet the following requirements: The contents of the emergency kit shall consist of those drugs needed to effectively manage a critical care incident or need of a patient. A copy of the list of the contents of the emergency kit shall be maintained both at the institution and the pharmacy supplying the drugs 2. All emergency kit drugs shall be provided and sealed by a pharmacist who is licensed to engage in the practice of pharmacy; 3. The supplying pharmacist and the medical staff of the institutional facility shall jointly determine the drugs, by identity and quantity, to be included in emergency kits; 4. Emergency kits shall be stored in secured areas to prevent unauthorized access, and to ensure a proper environment for preservation of the drugs within them; 5. The exterior of each emergency kit shall be labeled so as to clearly indicate that it is an emergency drug kit and that it is for use in emergencies only. The label shall contain a listing of the drugs contained in the kit, including name, strength, quantity, and expiration date of the contents, and the name, address(es), and telephone number(s) of the supplying pharmacist; 6. Drugs shall be removed from emergency kits only pursuant to a valid written order of an authorized practitioner; 7. Whenever an emergency kit is opened, the supplying pharmacist shall be notified and the pharmacist shall stock and reseal the kit within a reasonable time but not more than 72 hours (not 7 days), so as to prevent risk of harm to patients; and 8. The expiration date of an emergency kit shall be the earliest date of expiration of any drugs supplied in the kit.

Who may perform the practice of pharmacy? I. A person serving an internship who holds a professional degree in pharmacy from a school of pharmacy recognized by the Board. II. A person who holds an assistant's license. III. A person who holds a technician' license. A. I only B. I and II only C. II and III only D. All

(b) I and II only, [Alabama Administrative Code 680-x-2-.14(1),(2)]. (1). The practice of pharmacy shall mean the interpretation and evaluation of prescription orders; the compounding, dispensing, administering and labeling of drugs and devices; the participation in drug selection and drug utilization reviews and drug therapy management; the proper and safe storage of drugs and devices and the maintenance of proper records; the responsibility for advising, where necessary or where regulated, of therapeutic values, content, hazards and use of drugs and devices; and the offering or performing of those acts, services, operations or transactions necessary in the conduct, operation, management and control of pharmacy. (2). The only other persons who may perform the above tasks other than a licensed pharmacist, and then only under the immediate direct supervision of a pharmacist, are the following: (a). A person serving an internship who holds a professional degree in pharmacy from a school of pharmacy recognized by the Board. (b). A person serving an externship who is enrolled in a school of pharmacy recognized by the Board.(c). A person who holds an assistant's license.

Which of the following statements are TRUE regarding certification and registration related to nuclear pharmacists? I. The pharmacist engaged in the practice of nuclear pharmacy shall have training or shall have demonstrated previous training in the safe handling of radioactive pharmaceuticals. II. The pharmacist must be registered with and certified by the Alabama State Board of Pharmacy. III. The pharmacist must have completed no less than 10 hours of continuing education prior to re-certification related to nuclear pharmacy. A. I only B. I and II only C. III only D. All

(b) I and II only, [Alabama Administrative Code 680-x-2-.20(4)]. All pharmacists engaged in the practice of nuclear pharmacy shall have training or shall have demonstrated previous training in the safe handling of radioactive pharmaceuticals. They must be registered with and certified by the Alabama State Board of Pharmacy. Applications and re-certification with the Board is required biennially which shall expire on December 31 of even-numbered years on forms provided by the Board. Satisfactory completion of no less than 2 hours of continuing education prior to re-certification earned in the previous calendar year related to nuclear pharmacy shall be required.

Under an Alabama State Pharmacy Law, who may accept a new oral prescription from a licensed practitioner? I. Licensed pharmacists II. Registered interns III. Certified technicians A. I only B. I and II only C. II and III only D. All

(b) I and II only, [Alabama Pharmacy Practice Act 34-23-70(h) and Alabama Administrative Code 680-X-2-.14(2)]. According to Alabama State Pharmacy Law, only a licensed pharmacist or a registered intern/extern or a person who holds an assistant's license may accept an oral prescription of any nature. Upon so accepting such oral prescription, it must immediately be reduced to writing, and only a licensed pharmacist or an intern supervised by a licensed pharmacist may prepare a copy of a prescription or read a prescription to any person for purposes of providing reference concerning treatment of the person or animal for whom the prescription was written; and, when said copy is given, a notation shall be made upon the prescription that a copy has been given, the date given and to whom given.

Which of the following is/are TRUE about refilling a prescription drug or device when the pharmacist fails to obtain authorization from the prescriber? I. A pharmacist can fill the prescription drug or device if he thinks that the drug or device is required for continuation of therapy for chronic conditions. II. A pharmacist can fill the prescription drug or device if he thinks that the interruption of the therapy may produce serious health consequences. III. A pharmacist can fill the prescription drug if the refill of the prescription is not for a controlled substance. A. I only B. I and II only C. II and III only D. All

(b) I and II only, [Alabama Pharmacy Practice Act 34-23-75 (1)-to-(4) and Alabama Administrative Code 680-X-2-.26(1)(a),(b)]. In the event a pharmacist receives a request for a prescription refill and the pharmacist is unable to readily obtain refill authorization from the prescriber, the pharmacist may dispense a one-time emergency refill of up to a 72-hour supply of the prescribed medication, providing that: (1). The prescription is not a medicinal agent listed in Schedule II (schedule III**, IV and V are allowed).(2). The medication is essential to the maintenance of life or the continuation of therapy in a chronic condition. Only those drugs designed by a joint rule adopted by the board of pharmacy and the board of medical examiners shall be refilled, according to the procedure established in this section. (3). The dispensing pharmacist creates a written order containing all the prescription information required by the Alabama State Pharmacy Law. (4). The dispensing pharmacist notifies the prescriber of the emergency dispensing within 72 hours after such dispensing.

Which of the following Statements is/are TRUE about the dispensing of medications in the absence of a pharmacist in an institution pharmacy? I. Drugs shall be stored in a cabinet/enclosure constructed and located outside of the pharmacy area, to which only specifically authorized personnel may obtain access by key or combination. II. A complete audit of all activity concerning cabinets/enclosures shall be conducted no less than once per month. III. All drugs in cabinets are inventoried regularly based on institutional policy, but no less than every sixty days. A. I only B. I and II only C. III only D. All

(b) I and II only, [Alabama Uniform Controlled Substances 680-x-2-.18(4)(b)]. In the absence of a pharmacist, drugs shall be stored in a cabinet/enclosure constructed and located outside of the pharmacy area, to which only specifically authorized personnel may obtain access by key or combination, and which is sufficiently secure to deny access to unauthorized persons. The supervising pharmacist shall, in conjunction with the appropriate committee of the institutional facility, develop inventory listings of those drugs to be included in such cabinet/enclosure and determine who may have access, and shall ensure that: 1. The drugs are properly labeled; 2. Only prepackaged drugs are available, in amounts sufficient for immediate therapeutic requirements; 3. Whenever access to the cabinet/enclosure occurs, written orders of an authorized practitioner and proofs of use are provided; 4. All drugs therein are inventoried regularly based on institutional policy, but no less than every thirty (30) days; 5. A complete audit of all activity concerning such cabinet/enclosure is conducted no less than once per month.

Which of the following entities shall report to the department of the Controlled Substances Prescription Database? I. a licensed retail pharmacy II. a licensed mail order pharmacy III. a licensed hospital pharmacy A. I only B. I and II only C. II and III only D. All

(b) I and II only, [Alabama Uniform Controlled Substances Act 20-2-213(b)]. (a). Each of the entities designated in subsection (b) shall report to the department (the Controlled Substances Prescription Database), or to any entity designated by the department, controlled substances prescription information as designated by regulation pertaining to all Class II, Class III, Class IV, and Class V controlled substances in such manner as may be prescribed by the department by regulation. (b). The following entities or practitioners are subject to the reporting requirements of subsection (a): (1). Licensed pharmacies, NOT including pharmacies of general and specialized hospitals, nursing homes, and any other healthcare facilities which provide inpatient care, so long as the controlled substance is administered and used by a patient on the premises of the facility. (2). Mail order pharmacies or pharmacy benefit programs filling prescriptions for or dispensing controlled substances to residents of this state. (3). Licensed physicians, dentists, podiatrists, optometrists, or veterinarians who dispense Class II, Class III, Class IV, and Class V controlled substances directly to patients, or in the case of veterinarians, for administration to animals, but excluding sample medications. For the purposes of this article, sample mediations are defined as those drugs labeled as sample, not for resale under the laws and regulations of the Federal Food and Drug Administration. Controlled substances administered to patients by injection, topical application, suppository administration, or oral administration during the course of treatment is excluded from the reporting requirement.

Which of the following is/are correct filing method(s) for controlled substances? I. One file for CII, second file for III, IV and V and a third file for non-controlled substances. II. One file for CII and a second file for III, IV, V and non-controlled substances. III. One file for controlled and a second file for non-controlled substances. A. I only B. I and II only C. II and III only D. All

(b) I and II only, [Alabama uniform controlled Substances Act 20-2-58(d),(1),(2)]. Each registered pharmacy shall maintain the inventories and records of controlled substances as follows: (1). Inventories and records of all controlled substances listed in Schedules I and II shall be maintained separately from all other records of the pharmacy, and prescriptions for the substances shall be maintained in a separate prescription file. (2). Inventories and records of controlled substances listed in Schedules III, IV, and V shall be maintained either separately from all other records of the pharmacy or in the form that the information required is readily retrievable from ordinary business records of the pharmacy, and prescriptions for the substances shall be maintained either in separate prescription file for controlled substances listed in Schedules III, IV, and V only or in the form that they are readily retrievable from the other prescription records of the pharmacy.

According to Alabama State Pharmacy Law, which of the following mid-level practitioners may prescribe and/or dispense a Schedule II controlled substance in the course of their professional practices? I. Physician' assistant II. Nurse practitioner III. Optometrists A. I only B. I and II only C. II and III only D. All

(b) I and II only, [http://www.deadiversion.usdoj.gov/drugreg/practioners/mlp_by_state.pdf]. Pursuant to Title 21, Code of Federal Regulations, Section 1300.01(b28), the term mid-level practitioner means an individual practitioner, other than a physician, dentist, veterinarian, or podiatrist, who is licensed, registered, or otherwise permitted by the United States or the jurisdiction in which he/she practices, to dispense a controlled substance in the course of professional practice. Examples of mid-level practitioners include, but are not limited to, health care providers such as nurse practitioners, nurse midwives, nurse anesthetists, clinical nurse specialists and physician assistants who are authorized to dispense controlled substances by the state in which they practice. 1. AMB (Ambulance Service) 2. AS (Animal Shelters) 3. DOM (Doctors of Oriental Medicine) 4. ET (Euthanasia Technicians) 5. HMD (Homeopathic Physician) 6. MP (Medical Psychologists) 7. ND (Naturopathic Physician) 8. NP (Nurse Practitioners) 9. NH (Nursing Homes) 10. OD (Optometrists) 11. PA (Physician Assistants) 12. RPH (Registered Pharmacists) For the State of Alabama, only following mid-level practitioners can either prescribe or administer or both, schedule controlled substances. 1. AS (Animal Shelters) : 2N and 3N Sodium Pentobarbital and Sodium Pentobarbital W/Lidocaine (Line 1 Animal Shelter and Line 2 ET's Name) (administer /procure) 2. NP (Nurse Practitioners) : Schedule II to V controlled substances (administer and prescribe ) (Special permit requires for schedule II) 3. PA (Physician Assistants): Schedule II to V controlled substances (prescribe, administer and dispense) (Special permit requires for schedule II) 4. OD (Optometrists): Schedule III to V controlled substances (prescribe and administer)

JD comes to a pharmacy and requests a transfer of a prescription for Cylert from another pharmacy. His patient profile shows that three eligible refills have been left on the prescription. If both pharmacies, transferring and receiving, electronically sharing a real-time, on-line database, how many times may the original prescription be transferred between pharmacies? A. One-time only B. Maximum three times C. As many times as needed until the prescription expires D. Cannot be transferred

(b) Maximum three times [Code of Federal Regulation]. The one-time transfer of the original prescription information for a controlled substance listed in Schedules III or IV, if any authorized refills remain, for the purpose of dispensing is permissible between pharmacies within six (6) months from the date the prescription was issued. However, pharmacies electronically sharing a real-time, on-line database may transfer up to the maximum refills permitted by the law and prescriber's authorization.

A prescription for schedule III controlled drug is prepared by a licensed practitioner to submit via e-prescribing to the pharmacy of patient's choice. The licensed practitioner, instead of submitting it via e-prescribing, print out the prescription on hard paper with his electronic signature on it. The patient presents this prescription to a pharmacist. What shall the pharmacist do? A. Fill as it is. B. Suggest the physician that the prescription is missing his wet signature. C. Ask the physician to submit via e-prescribing since the prescription contains electronic signature on it. D. Do not fill the prescription.

(b) Suggest the physician that the prescription is missing his wet signature, [http://www.albop.com/FAQ.aspx See FAQ PRESCRIPTIONS: CONTROLLED SUBSTANCES Q.7]. A prescription for a controlled substance must include the following information: a. Date of issue b. Patient's name and address c. Practitioner's name, address, and DEA registration number d. Drug name e. Drug strength f. Dosage form g. Quantity prescribed h. Directions for use i. Number of refills (if any) authorized j. Manual signature of prescriber A prescription must be written in ink or indelible pencil or typewritten and must be manually signed by the practitioner. An individual may be designated by the practitioner to prepare the prescriptions for his/her signature. The practitioner is responsible for making sure that the prescription conforms in all essential respects to the law and regulation. Prescriptions for schedule II controlled substances must be written and be signed by the practitioner. In emergency situations, a prescription for a schedule II controlled substance may be telephoned to the pharmacy and the prescriber must follow up with a written prescription being sent to the pharmacy within seven days. Prescriptions for schedules III through V controlled substances may by written, oral or transmitted by fax. A prescription which is printed or prepared in the prescriber' office for a controlled drug may NOT have a signature from the printer, or an electronic signature. All prepared or hard copy prescriptions for controlled substances must have a "wet" signature. This means the prescription must be signed manually.

In the event of an unanticipated, permanent absence of the collaborating pharmacist, a previously approved covering pharmacist may be designated as a temporary collaborating pharmacist for a period of up to 180 days. True or false

(b), False [AL Rule 680-X-2-.44(4)(l) and (5). Collaborative Practice]. In the event the collaborating pharmacist is not readily available, provisions shall be made by the pharmacist for coverage by a pharmacist who is pre-approved by the Board of Pharmacy and familiar with these rules. In the event of an unanticipated, permanent absence of the collaborating pharmacist, a previously approved covering pharmacist may be designated as a temporary collaborating pharmacist for a period of up to sixty (60) days. During the sixty (60) day time period, a new CPA designating a new collaborating pharmacist should be submitted for approval. (a). Prior to termination or non-renewal of a CPA, the collaborating physician and the collaborating pharmacist shall arrange for uninterrupted continuation of the patient's drug therapy, in accordance with the terms of the CPA. (b). When a CPA is not renewed or the CPA is otherwise terminated, the collaborating pharmacist and collaborating physician shall inform all active patients in writing of the termination and of the procedures in place for continuation of the patient's drug therapy, in accordance with the terms of the CPA. (c). The collaborating pharmacist and collaborating physician shall each inform their respective board in writing of the effective date of the termination of the CPA and the reasons for such termination. Failure to notify the respective board of termination may be considered a violation of these rules and regulations. (d). The collaborating physician has an ongoing responsibility for patient care unless or until the physician patient relationship is terminated.

The registered technician shall submit to the Board of Pharmacy documentation of the satisfactory completion of vaccine requirements within ________ of completion. A. 24 hours B. 7 days C. 10 days D. 30 days

(c) 10 days, [AL Rule 680-X-2-.03(2)]. The registered technician shall submit to the Board of Pharmacy documentation of the satisfactory completion of vaccine requirements within 10 days of completion. The Secretary of the Board shall issue to the registered technician a certificate for immunization authority, which shall be displayed in a conspicuous place. The supervising pharmacist shall ensure prior to any registered technicians providing immunizations completion of the immunization training set out in the law and is acting in compliance with all requirements of the rule.

All pharmacists engaged in compounding and dispensing of parenteral solutions including cytotoxic agents shall successfully complete a Board approved certifying course for parenteral pharmacists. Such course shall be a minimum of: A. 30 contact hours. B. 10 contact hours. C. 5 contact hours. D. 15 contact hours.

(c) 5 contact hours, [Alabama Administrative Code 680-X-2-.19(3)]. All pharmacists engaged in compounding and dispensing of Parenteral Solutions including cytotoxic agents shall register biennially which shall expire on December 31 of even-numbered years with the Board of Pharmacy. Programs submitted for certification shall be a minimum of five (5) contact hours, including didactic and hands on experience. All programs certified by the Board shall require a written exam as a part of the training. It shall be the responsibility of the supervising pharmacist to verify the parenteral certification of pharmacists involved in the preparation of parenteral products.

What would be minimum continuing education hours of live presentation required each renewal cycle to renew a pharmacist license in Alabama? A. 3 hours B. 2 hours C. 6 hours D. None of the above

(c) 6 hours, [Alabama Administrative Code 680-X-2-.36(3),(4)]. (1). Pharmacists shall complete thirty (30) hours of continuing education each renewal cycle as a condition of licensure renewal. By submitting the biennial renewal, a pharmacist is representing their compliance with this requirement by the end of the relevant renewal cycle. (2). In order to receive credit for continuing education, the continuing education shall be previously approved by the Board. Any requests for approval of continuing education shall be submitted to the Board no less than thirty (30) calendar days prior to offering of the continuing education. A condition of approval shall be that the continuing education is pertinent to the practice of pharmacy. However, this requirement shall not apply to ACPE or ACCME approved continuing education courses for which a program number is available. (3). Continuing Education may be completed by either attendance or by distance based program, video or by publications; however, a pharmacist must complete at least six (6) hours of live continuing education through attendance at a course(s), within the renewal cycle. (4). It is the responsibility of each pharmacist to maintain and compile accurate records relating to all continuing education courses or activities they have attended and completed. It shall be the responsibility of each pharmacist to maintain above described documentation and information pertaining to each year for a period of two (2) years and this information shall be submitted to the Board of Pharmacy within thirty (30) calendar days after a request for the same by the Board.

The printout of the day's controlled substance prescription order refill data must be provided to each pharmacy using a computerized system within _________ of the date on which the refill was dispensed. A. 24 hours B. 48 hours C. 72 hours D. 96 hours

(c) 72 hours, [Alabama Administrative Code 680-x-2-.15(c)(1)]. (a) The computerized system shall provide for the storage and retrieval of original prescription orders as follows: 1. The original prescription number. 2. The prescribing practitioner's name. 3. Full name and address of the patient. 4. Date the original prescription was issued and the date it was dispensed, if different from the date of issue. 5. Name, strength, dosage form, and quantity of drug dispensed. 6. Total number of refills authorized by the prescriber. 7. Quantity dispensed. 8. In the case of controlled substance, the DEA registration number and the Alabama controlled substances number of the prescribing practitioner. 9. Identification of the dispensing pharmacist. (b) The computerized system shall provide for the retrieval of the refill history of all prescriptions entered into the computer. This refill history shall include: 1. The name of the drug. 2. Date of all refills. 3. Quantity dispensed originally and on each refill. 4. Identification of the dispensing pharmacists originally and for each refill. 5. The total number of refills dispensed to date for that prescription order. (c). Documentation of the fact that the refill information entered into the computer each time a pharmacist refills an original prescription order for a Schedule III, IV, or V controlled substance is correct must be provided by the individual pharmacist who makes use of such a system in either of two ways. 1. If such a system provides a hard-copy printout of each day's controlled substance prescription order refill data, that printout shall be verified, dated, and signed. The individual pharmacist must verify that the data indicated is correct and then sign this document in the same manner as he or she would sign a legal document. This printout of the day's controlled substance prescription order refill data must be provided to each pharmacy using such a computerized system within 72 hours of the date on which the refill was dispensed; or in lieu of such a printout, the pharmacy shall maintain a bound log book, or separate file, in which each individual pharmacist involved in such dispensing shall sign a statement each day in the same manner as he or she would sign a legal document, attesting to the fact that the refill information entered into the computer that day has been reviewed by him or her and is correct as shown. Any such computerized system shall have the capability producing a printout of any refill data which the user pharmacy is responsible for maintaining under the Alabama Controlled Substances Act and its implementing regulations. For example, this would include a refill-by-refill audit trail for any specified strength and dosage form of any controlled substance (by either brand, generic name, or both). Such a printout must include the name of the prescribing practitioner, name and address of the patient, quantity dispensed on each refill, date of dispensing on each refill, name or identification code of the dispensing pharmacist, and the number of the original prescription order.

Pharmacists who have not successfully completed an initial certification course for consultants which has been approved by the Board will not be registered or reregistered as consultants with the Board until they have completed said course. The said course shall be consisted of: A. 30 hours. B. 60 hours. C. 8 hours. D. None of the above

(c) 8 hours, [Alabama Administrative Code 680-x-2-.08(a)(5) ]. After January 1, 1996, pharmacists who have not successfully completed an initial certification course for consultants, which has been approved by the Board, will not be registered or reregistered as consultants with the Board until they have completed said course. Pharmacists must have taken the initial consultant certification course and have successfully completed an examination with a passing score of 75. The initial certification course shall be a eight (8) hour approved course consisting of the following subject matters: (i). Regulations and laws, both state and federal, pertaining to services provided by consultant pharmacists. (ii). Policy and Procedures. (iii). Administrative Responsibilities. (iv). Professional Responsibilities. (v). Consultant Pharmacy Opportunities - History and Overview. (vi). Drug Regimen Review. (vii). Ethics in Consultant Pharmacy (viii). Impact of Consultant Pharmacy on the Total Healthcare System. (ix). Drug Therapy/Disease State Monitoring.

Which of the following information is/are TRUE ABOUT a licensed pharmacist who has temporarily left the premises? I. a sign shall be posted in a prominent place on the prescription counter, easily viewed by the public, giving the pharmacist's name, the hours he will be away from the premises. II. the address and telephone number where he can be reached. III. if an alternate supervising pharmacist is being used, the sign shall give that pharmacist's name, address and telephone number where he can be reached. A. I only B. I and II only C. All D. None of the above

(c) All, [Alabama Administrative Code 680-X-2-.06]. In the event a licensed pharmacist who is supervising an assistant has left the premises, a sign shall be posted in a prominent place on the prescription counter, easily viewed by the public, giving the pharmacist's name, the hours he will be away from the premises, and the address and telephone number where he can be reached; or if an alternate supervising pharmacist is being used, the sign shall give that pharmacist's name, address and telephone number where he can be reached. The supervising pharmacist must be able to return to the store premises within a reasonable period of time. The State Board of Pharmacy defines reasonable in this context to mean no longer than 30 minutes following a request for his appearance.

Access to the automated dispensing system shall be controlled by the Managing Pharmacy and shall be limited to: I. Licensed pharmacists II. Registered pharmacy technicians III. Licensed nurses A. I only B. I and II only C. All D. None of the above

(c) All, [Alabama Administrative Code 680-X-2-.18(6)(d)]. A Managing Pharmacy may utilize an automated dispensing system provided: 1. The Supervising Pharmacist of the Managing Pharmacy is responsible for the operation of the automated dispensing system. There is no requirement that a pharmacist be physically present at the site of the automated dispensing system. However, a pharmacist of the Managing Pharmacy must have access to the equipment and all transaction information at all times. 2. Access to the drugs and information contained within the automated dispensing system is secured through the use of positive identification. 3. Access to the automated dispensing system shall be controlled by the Managing Pharmacy and shall be limited to: (i) Licensed nurses (ii) Licensed pharmacists and registered pharmacist-interns (iii) Registered pharmacy technicians (iv) Authorized field service personnel for maintenance purposes and only while under direct observation of a licensed nurse, a licensed pharmacist, or a registered pharmacy technician. 4. Medications delivered to the skilled nursing facility but not yet stocked into the automated dispensing system are stored in a secure manner and in compliance with the policies and procedures agreed upon by the Managing Pharmacy and the leadership of the facility. 5. Restocking of the automated dispensing system shall be limited to a licensed pharmacist or a registered pharmacy technician of the Managing Pharmacy, a licensed nurse of the facility, or other licensed healthcare personnel approved by the Board of Pharmacy. 6. A pharmacist of the Managing Pharmacy conducts an on-site physical inventory of the contents of the automated dispensing system at least quarterly.

In a hospital without a licensed hospital pharmacy, who shall supervise the drug or medicine room? I. a staff pharmacist of the hospital II. a consultant pharmacist of the hospital III. a licensed practitioner of medicine A. I only B. I and II only C. II and III only D. All

(c) II and III only [Alabama Pharmacy Practice Act 34-23-74]. Every pharmacy located in a hospital, skilled nursing home, or other related institution in this state shall be under the supervision of a licensed pharmacist. In general hospitals, skilled nursing homes, and extended care facilities not operating a pharmacy, the drug or medicine room shall be under the direct supervision and direction of a consulting pharmacist or a member of the medical staff who shall be a licensed practitioner of medicine. In nursing homes which are not classified by the State Board of Health as skilled nursing homes, maternity homes, homes for the aged, domiciliary institutions, and all related institutions except those operated by and in conjunction with a licensed hospital, medicines or drugs bearing the wording on the label "caution, federal law prohibits dispensing without prescription" or similar wording that causes the medicines or drugs to be known as prescription legend drugs shall be furnished by a licensed pharmacy on the prescription of a licensed practitioner of medicine for individual patients, and there shall be no prescription legend drugs on the premises of these institutions other than those so prescribed except an emergency kit as authorized by the State Board of Health. In hospitals and skilled nursing homes using vending machines or mechanical devices for the storage and dispensing of drugs, the machines or devices shall be stocked only under the supervision of a licensed pharmacist, and the drugs may be dispensed from the machine or device only by an individual acting in accordance with established institutional hospital pharmacy policy.

Which of the following is/are the minimum requirement(s) to work as a certified pharmacy technician? I. An applicant shall be age 18 or older. II. Every pharmacy technician registered by the Alabama State Board of Pharmacy shall, prior to registration, complete three (3) hours of continuing education annually, one hour of which shall be live presentation. III. An applicant must have submitted a written application on a form provided by the Board of Pharmacy. A. I only B. I and II only C. II and III only D. All

(c) II and III only, [Alabama Administrative Code 680-x-2-.14(6),(10)]. In order to be registered as a pharmacy technician in this State, an applicant shall: (a). Have submitted a written application on a form provided by the Board of Pharmacy (b). Shall be age 17 or older (not 18). (c). Every pharmacy technician registered by the Alabama State Board of Pharmacy shall, prior to registration, complete three (3) hours of continuing education annually, one hour of which shall be "live" presentation. All pharmacy technicians shall register with the Alabama State Board of Pharmacy.(d). Each technician registered by the Board shall notify the board in writing within 10 days on change of employment. The notice shall contain his/her name, registration number, the name of the pharmacy where formerly employed and the name of the pharmacy where currently employed. (e). The registration for pharmacy technician shall expire on December 31 of odd-numbered years.

Which of the following shall be required on a dispensing container when drug is filled by using the Central Prescription Filling? I. Name and address of the pharmacy that fills the prescription II. a "Unique Identifier" of the pharmacy filling the prescription. III. Name and address of the pharmacy that dispenses the filled prescription. A. I only B. I and II only C. II and III only D. All

(c) II and III only, [Alabama Administrative Code 680-x-2-.30(5)]. Prescription Labeling for Central Fill Prescriptions. The filling pharmacy shall: (a). Place on the prescription label a "Unique Identifier" of the pharmacy filling the prescription and name and address of the pharmacy that dispenses the filled prescription. (b). Indicate in some manner which pharmacy filled the prescription (e.g., "Filled by ABC Pharmacy for XYZ Pharmacy); and (c). Comply with all other labeling requirements of federal and state statutes.

What are requirements to become a licensed pharmacist under an Alabama State Pharmacy Law? I. An applicant shall be not less than 18 years of age. II. An applicant be of good moral character and temperate habits. III. An applicant shall hold a professional degree from a division, school, college, or a university department of pharmacy recognized by the State Board of Pharmacy. A. I only B. I and II only C. II and III only D. All

(c) II and III only, [Alabama Pharmacy Practice Act 34-23-51]. Every person who desires to practice pharmacy within this state shall file with the secretary of the board his or her written application for licensure upon forms furnished by the board not less than 10 days prior to his or her examination. The applicant shall furnish satisfactory proof that he or she is at least 19 years of age (Not 18 years of age), of good moral character, and that he or she holds a professional degree from a division, school, college, or a university department of pharmacy recognized by the State Board of Pharmacy. The applicant shall have completed an approved practical training program under the supervision of a licensed pharmacist in a site recognized by the board as qualified for training pharmacy externs and interns, the training standards to be established by the board as long as the standards are not less than those set by the National Association of Boards of Pharmacy. The completion of the practical training requirements shall be attested by affidavit from the licensed pharmacist preceptor under whom the training is served.

In the case of unauthorized refills, the dispensed quantity of the refilled drug should be limited to a: A. One-day supply. B. Seven-day supply. C. Three-day supply. D. Thirty-day supply.

(c) [Alabama Pharmacy Practice Act 34-23-75 (1)-to-(4)]. In case of unauthorized refills, the dispensed quantity of refilled drug should be limited to a three-day supply. The pharmacist must notify the authorized prescriber within 72 hours of dispensing the drug.

A collaborative practice agreement must be reviewed and renewed by the collaborating pharmacist and collaborating physician every ________. A. six months B. twelve months C. two years D. quarterly

(c), [AL Rule 680-X-2-.44(4)(e). Collaborative Practice]. A collaborative practice agreement must be reviewed and renewed by the collaborating pharmacist and collaborating physician every 2 years. A copy of the collaborative practice agreement with any supporting documentation and/or patient information must be kept in a readily retrievable form at the pharmacy for a minimum of 2 years.

Which of the following shall every pharmacy licensed in this state have? I. the latest edition of Drug Facts and Comparison. II. hot and cold running water in the prescription area. III. a prescription balance with appropriate sensitivity and appropriate weights. A. I only B. I and II only C. I and III only D. All

(d) All, [Alabama Administrative Code 680-X-2-.04]. (1). Every pharmacy licensed in this state shall have on hand the following technical equipment; the last edition and/or revision of "Facts and Comparison" or any reference book or electronic media sufficient to meet the level of its pharmacy practice; hot and cold running water in the prescription area; a prescription balance with appropriate sensitivity and appropriate weights. (2). Every satellite pharmacy of licensed institutional pharmacies shall have all of the above with the exception of weight equipment. In addition, community pharmacies shall have on hand an exempt narcotic register. (3). In addition, all pharmacies shall have on hand any technical equipment commensurate with its level and type of practice, i.e. hoods for I.V. preparations.

Whenever any drug is not available from floor supplies or cabinet/enclosure, and such drug is required to treat the immediate needs of a patient whose health would otherwise be jeopardized, such drug may be obtained from the Pharmacy if the following condition(s) is/are met: I. One supervisory nurse or physician in any given shift is responsible for obtaining drugs from the pharmacy .II. Removal of any drug from the Pharmacy by an authorized designee must be pursuant to written orders of an authorized practitioner. III. Removal of any drug from the Pharmacy by an authorized designee must be recorded on a suitable form showing patient name, room number, name of Drug, strength, amount, date, and time and signature of designee. A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Administrative Code 680-X-2-.18(4)(c)]. Whenever any drug is not available from floor supplies or cabinet/enclosure, and such drug is required to treat the immediate needs of a patient whose health would otherwise be jeopardized, such drug may be obtained from the pharmacy in accordance with the requirements of this following paragraph. One supervisory nurse or physician in any given shift is responsible for obtaining Drugs from the pharmacy. The responsible person shall be designated in writing by the appropriate committee of the Institutional Facility. Removal of any drug from the Pharmacy by an authorized designee must be pursuant to written orders of an authorized practitioner and must be recorded on a suitable form showing patient name, room number, name of drug, strength, amount, date, and time and signature of designee. The form shall be left with the container from which the drug was removed.

The request for approval to use an automated dispensing system shall include: I. A description of the type, manufacturer, and model number of an automated dispensing system along with a description of how the system is to be used. II. The specific location(s) within the facility where the automated dispensing system will be placed. III. The name and permit number of the Managing Pharmacy. A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Administrative Code 680-X-2-.18(6)(c)]. 1. The Managing Pharmacy shall submit a written request to the Board of Pharmacy for approval to use an automated dispensing system. The Board of Pharmacy shall determine at which future meeting the request shall be considered. Requests must be submitted no less than 30 days prior to the Board of Pharmacy meeting at which the request will be considered. 2. The request for approval to use an automated dispensing system shall include: (a). written policies and procedures for the automated dispensing system specific to the automation to be used, (b). the name and address of the facility in which the automation will be used, (c). the name and permit number of the Managing Pharmacy, (d). a description of the automation (type, manufacturer, and model) along with a description of how the system is to be used, (e). The specific location(s) within the facility where the automated dispensing system will be placed, and (f). The date the automation will be placed into operation. The Board of Pharmacy must be notified at least 30 days prior to use.

What are commonly used equipments for a nuclear pharmacy? I. Well scintillation counters II. Fume hood III. Geiger-Mueller (GM) survey meters A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Administrative Code 680-X-2-.20(6)(b)]. Nuclear Pharmacy Equipments: 1. Fume hood 2. Shielded radiation containment drawing section 3. Dose calibrator 4. Well scintillation counters 5. Area rate meters 6. Geiger-Mueller (GM) survey meters 7. Refrigerator 8. Microscope9. Hemocytometer 10. Leaded glass syringe and vial shields 11. Personnel radiation detection devices 12. Radioactive storage container and/or storage vault for waste materials

Who may possess a key for pharmacy? I. A registered pharmacist II. One unregistered person designated by the owner of the pharmacy. III. The highest ranking official of the First Responders. A. I only B. I and II only C. III only D. All

(d) All, [Alabama Administrative Code 680-x-2-.11(1)]. At all times registered Pharmacists designated by the licensee must have all keys or other controlled access device or method in their possession. The owner of the pharmacy may designate one (1) unregistered person to have a key or other controlled access device or method to the pharmacy. The Supervising Pharmacist must agree to this arrangement. The permit holder (owner) must execute a signed agreement with the individual in possession of a key or other controlled access device or method to the pharmacy and must submit a copy to the Board of Pharmacy for approval prior to issuing a key or other controlled access device or method to any person that does not hold an active pharmacist license in the State of Alabama. Forms for this purpose may be obtained from the Board of Pharmacy. Further, if the municipality or other government authority in the jurisdiction where a pharmacy is located requires compliance with a Fire Code that mandates making a key or other controlled access device or method to the premises available to First Responders, the permit holder (owner) must execute a signed agreement with the highest ranking official of the agency that wants access to the key or other controlled access device or method and submit a copy to the Board of Pharmacy for approval prior to providing access to a key or other controlled access device or method; the Knox Box or other system for accessing the key or other controlled access.

A certified pharmacy technician shall NOT perform which of the following tasks? I. Document the receipt of a controlled substance into inventory. II. Prepare a copy of a prescription or read a prescription to another person. III. Counsel a patient on medications or perform a drug utilization review. A. I only B. I and II only C. III only D. All

(d) All, [Alabama Administrative Code 680-x-2-.14(4)]. In order to adequately protect the public health, certified technicians shall NOT: (a). Communicate, orally or in writing, any medical, therapeutic, clinical or drug information, or communicate any information recorded on a patient profile that requires professional judgment.(b). Document the receipt of a controlled substance into inventory. (c). Accept by oral communication a new prescription of any nature. (d). Prepare a copy of a prescription or read a prescription to another person. (e). Provide a prescription or medication to a patient without a pharmacist's verification as to the correctness of the prescription or medication. For the purpose of this rule, verification shall mean that the licensed pharmacist shall be aware of the patient profile, DUR, computer overrides and drug interactions as well as the correctness of the selected medication and labeling. (f). Counsel a patient on medications or perform a drug utilization review. (g). Perform any task that requires the professional judgment of a pharmacist. (h). Perform any task that is in violation of any federal, State or local pharmacy regulations.

Which of the following information is/are TRUE about administering patient's own brought drugs in an institution? I. Whenever patients bring drugs into an Institutional Facility, such drugs shall not be administered unless they can be precisely identified. II. Administration shall be pursuant to a practitioner's order only. III. If such Drugs are not to be administered, they shall be given to an adult member of the patient's immediate family for removal from the Institution. A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Administrative Code 680-x-2-.18(5)(c)]. (c). Whenever patients bring drugs into an Institutional Facility, such drugs shall not be administered unless they can be precisely identified. Administration shall be pursuant to a practitioner's order only. If such Drugs are not to be administered, they shall be given to an adult member of the patient's immediate family for removal from the Institution or follow written policy provided by the Supervising Pharmacist.

Which of the following information is/are TRUE ABOUT automated dispensing system located in skilled nursing facilities? I. A Managing Pharmacy may use an automated dispensing system to meet the emergency medication needs and the STAT medication needs of residents in skilled nursing facilities. II. The automated dispensing system must be located in a skilled nursing facility that holds a valid and current contract with a Managing Pharmacy to provide pharmacy services to that facility. III. The automated dispensing system shall be considered an extension of the Managing Pharmacy. A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Administrative Code 680-x-2-.18(6)(a)(b)]. "Automated dispensing system" means an electromechanical system that performs operations or activities related to the storage and dispensing of medications and which is capable of collecting, controlling, and maintaining all required transaction information and records. "Managing Pharmacy" means a pharmacy physically located in Alabama, holding a current pharmacy permit issued by the Alabama Board of Pharmacy, and which is responsible for supplying prescribed medications for patients in a skilled nursing facility and for the safe operation of any automated dispensing system used in the facility. A Managing Pharmacy may use an automated dispensing system to meet the emergency medication needs and the STAT medication needs of residents in skilled nursing facilities. The automated dispensing system must be located in a skilled nursing facility that holds a valid and current contract with a Managing Pharmacy to provide pharmacy services to that facility. The automated dispensing system shall be considered an extension of the Managing Pharmacy.

Which of the following requirements must be fulfilled to ensure appropriate security and authenticity of electronically transmitted prescriptions? I. Prescriber internal sender identification shall be required on an electronically transmitted prescription. II. Pharmacy internal receiver identification shall be required on an electronically transmitted prescription. III. Transmitting system identifier shall be required on an electronically transmitted prescription. A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Administrative Code 680-x-2-.32(1)(b)]. Electronically prescriptions may be transmitted directly to the pharmacy or transmitted over an e-prescription network approved by the Board. All such transmissions must ensure appropriate security and authenticity to include the following: 1. An electronic signature process enabling the pharmacy to ensure the identity of the prescriber; 2. Date and time stamp; 3. Transmitting system identifier; 4. Prescriber internal sender identification; and 5. Pharmacy internal receiver identification.

Who may enter and inspect a permit holder's pharmacy during normal business hours? I. Federal officers II. County and municipal officers III. The agents and officers of the department of public safety A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Controlled Substances 20-2-91(a)]. Prescriptions, orders and records required by the Alabama Pharmacy Law and stocks of controlled substances enumerated in schedules I, II, III, IV, and V shall be open for inspection only to federal, state, county and municipal officers, the investigators to the board of dental examiners, and the agents and officers of the department of public safety whose duty it is to enforce the laws of this state or of the United States relating to controlled substances.

Which of the following statements are TRUE about the preparation of compounded products to be sold by pharmacists over the counter without a prescription order? I. A compounded product shall be sold directly to the consumer after professional interaction or consultation between the pharmacist and the consumer. II. The product shall not contain an ingredient which exceeds recommended strengths and doses for over the counter drugs. III. The product may not be sold in bulk to other pharmacies or vendors for resale. A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Pharmacy Practice Act 34-23-159]. A pharmacy may prepare a compounded drug product to be sold over the counter without a prescription order. The product shall not contain an ingredient which exceeds recommended strengths and doses for over the counter drugs. The finished product shall not be one for which a prescription is required. It shall be properly labeled with the product' name, directions for use, list of active ingredients, and any necessary warnings. A compounded product shall be sold directly to the consumer after professional interaction or consultation between the pharmacist and the consumer. The product may be prepared in advance in reasonable amounts in anticipation of estimated needs. The product shall be stored within the prescription department. The product may not be sold in bulk to other pharmacies or vendors for resale.

Which of the following statements is/are TRUE regarding the temporary absences of licensed pharmacist? I. Not to exceed three hours daily. II. Not to exceed more than one and one-half hours at any one time. III. Not to exceed more than one week for an illness. A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Pharmacy Practice Act 34-23-70(a)]. Every pharmacy when opened for business shall be under the personal supervision of a duly licensed pharmacist who shall have personal supervision of not more than one pharmacy at the same time. During temporary absences of the licensed pharmacist, not to exceed three hours daily or more than one and one-half hours at any one time, nor more than one week for an illness, the prescription department shall be closed, and no prescriptions are to be filled. During the temporary absence of a pharmacist, a sign shall be placed on the prescription counter in a prominent location easily seen by the public stating, "Prescription Department Closed, No Pharmacist on Duty.

Which of the following statements are TRUE about theft or loss of controlled substances under the Alabama State Pharmacy Law? I. A pharmacy shall notify the Field Division Office of the DEA and the Alabama State Board of Pharmacy of the theft or significant loss of any controlled substances upon discovery of such loss or theft. II. The pharmacy shall also complete DEA form "Report of Theft or Loss of Controlled Substances," which may be obtained from the Board of Pharmacy or DEA Office. III. The pharmacy shall keep a duplicate copy for its records, forward two (2) copies, the original and duplicate copy, to the Field Division Office of DEA and provide one (1) duplicate copy to the Alabama State Board of Pharmacy. A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Uniform Controlled Substances 680-x-3-.07(1),(2)]. A pharmacy shall notify the Field Division Office of the DEA and the Alabama State Board of Pharmacy of the theft or significant loss of any controlled substances upon discovery of such loss or theft. The pharmacy shall also complete DEA form "Report of Theft or Loss of Controlled Substances," which may be obtained from the Board of Pharmacy or DEA Office. Four copies must be made of the report. The pharmacy shall keep a duplicate copy for its records, forward two copies, the original and duplicate copy, to the Field Division Office of the DEA and provide one duplicate copy to the Alabama State Board of Pharmacy.

Any ephedrine or pseudoephedrine, their salts or optical isomers, or salts of optical isomers sold within a pharmacy must be sold by: I. an individual licensed as a pharmacist II. a pharmacy technician licensed by the Alabama Board of Pharmacy III. an employee of the pharmacy under the direct supervision of pharmacist A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Uniform Controlled Substances Act 20-2-190(c)(1)]. It shall be unlawful for any person, business, or entity to knowingly sell any ephedrine or pseudoephedrine, their salts or optical isomers, or salts of optical isomers unless sold from a pharmacy licensed by the Alabama Board of Pharmacy. Any ephedrine or pseudoephedrine, their salts or optical isomers, or salts of optical isomers sold within a pharmacy must be sold by an individual licensed as a pharmacist, a pharmacy technician licensed by the Alabama Board of Pharmacy, or by an employee of the pharmacy under the direct supervision and control of a licensed pharmacist.

What are valid identification cards for selling an over-the-counter Schedule V controlled substances or pseudoephedrine or ephedrine related products? I. a valid, unsuspended driver' license of Alabama State II. a United States or foreign passport III. a United States Uniformed Services Privilege Identification Card

(d) All, [Alabama Uniform Controlled Substances Act 20-2-190(c)(5)(a)]. Each pharmacy selling an over-the-counter Schedule V controlled substances or pseudoephedrine or ephedrine related products shall require the purchaser of the product or products to be at least 18 years of age, to provide a valid, unsuspended driver' license or non-driver identification card issued by this state, a valid, unsuspended driver' license or non-driver identification card issued by another state, a United States Uniformed Services Privilege and Identification Card, or a United States or foreign passport, and to sign a record of each transaction. A record of each transaction shall include the magnetic transfer or electronic entry of information data from the identification card into the system, as well as the type of identification card used, including the number, name, date of birth and current, valid address of the purchaser, the date and time of the sale, the name of the product being sold, as well as the total quantity in grams, of ephedrine or pseudoephedrine being sold.

The Board of Medical Examiners may grant a Qualified Alabama Controlled Substances Registration Certificate (QACSC) to a certified registered nurse practitioner (CRNP) or certified nurse midwife (CNM) who: I. Is practicing all rules and regulations pertaining to collaboration between a qualified physician and a qualified CRNP or a CNM. II. Submits proof of successful completion of a course or courses approved by the board. III. Provides accurate and complete documentation of 12 or more months of active, clinical practice with one or more collaborative practices agreement. A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Uniform Controlled Substances Act 20-2-252]. The Board of Medical Examiners may grant a Qualified Alabama Controlled Substances Registration Certificate (QACSC) to a certified registered nurse practitioner (CRNP) or certified nurse midwife (CNM) who: (1). Is practicing all rules and regulations pertaining to collaboration between a qualified physician and a qualified CRNP or a CNM. (2). Submits proof of successful completion of a course or courses approved by the board which includes advanced pharmacology and prescribing trends relating to controlled substances and which is consistent with the same requirements for other mid-level providers. (3). Provides accurate and complete documentation of 12 or more months of active, clinical practice with one or more collaborative practices agreement which has received final approval from the Board of Medical Examiners and the Alabama Board of Nursing.

Faxing a prescription for Schedule II controlled drugs may serve as the original prescription only if: I. A prescription written for a Schedule II narcotic substance to be compounded for the direct administration to a patient by parenteral route. II. A prescription written for Schedule II substances for a resident of a long-term care facility. III. A prescription written for Schedule II substances for a resident of Hospice care certified by Medicare. A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Uniform Controlled Substances Act 20-2-58(b),(c) and Alabama Uniform Controlled Substances Act 680-X-3-.10(2)(b)]. A prescription for a Schedule II controlled substance may be transmitted by the practitioner or the agent of the practitioner, but not by the patient or patient' agent, to a pharmacy via facsimile equipment, provided the original written, signed prescription is presented to the pharmacist for review prior to the actual dispensing of the controlled substance. Faxing a prescription for Schedule II controlled drugs may serve as the original prescription only if: 1. A prescription written for a Schedule II narcotic substance to be compounded for the direct administration to a patient by parenteral, intravenous, intramuscular, subcutaneous, or intraspinal infusion may be transmitted by the practitioner or the agent of the practitioner to the home infusion pharmacy by facsimile. 2. A prescription written for Schedule II substances for a resident of a long-term care facility, which include hospice patients, may be transmitted by the practitioner or the agent of the practitioner to the dispensing pharmacy by facsimile.

Which of the following data elements shall be transferred to the controlled substance monitoring database? I. Name of the prescribing practitioner. II. Name of person and full address for whom the prescription was written. III. National Drug Code (NDC) of controlled substance dispensed. A. I only B. I and II only C. II and III only D. All

(d) All, [Alabama Uniform controlled Substances Act 20-2-213(d)]. The Prescription Drug Monitoring Program (PDMP) is a program developed to promote the public health and welfare by detecting diversion, abuse, and misuse of prescription medications classified as controlled substances under the Alabama Uniform Controlled Substances Act. The law requires anyone who dispenses Class II, III, IV, V controlled substances to report daily the dispensing of these drugs to the database (http://www.alabamapublichealth.gov/PDMP/).(d). The following data elements shall be used in transmitting controlled substance prescription information to the controlled substance monitoring database: (1). Name or other identifying designation of the prescribing practitioner. (2). Date prescription was filled or medications dispensed. (3). Name of person and full address for whom the prescription was written or to whom the medications were dispensed. (4). National Drug Code (NDC) of controlled substance dispensed. (5). Quantity of controlled substance dispensed. (6). Name or other identifying designation of dispensing pharmacy or practitioner. (7). Other data elements consistent with standards established by the American Society for Automation in Pharmacy as may be designated by regulations adopted by the department. (8). Method of payment and third-party payor identification of the controlled substance dispensed.

What changes may a pharmacist make to a prescription written for a controlled substance listed in schedule III-V after verbally consulting with a practitioner? I. The quantity of the controlled substance II. The dosage form of the controlled substance III. The issue date of the controlled substance A. I only B. III only C. None of the above D. All

(d) All, [http://www.albop.com/FAQ.aspx PRESCRIPTIONS: CONTROLLED SUBSTANCES Q.18]. The pharmacist may add or change the patient' address upon verification. The pharmacist may add or change the dosage form, drug strength, drug quantity, directions for use, or issue date only after consultation with and agreement of the prescribing practitioner. Such consultations and corresponding changes should be noted by the pharmacist on the prescription. If the prescription is missing the prescriber' signature, the pharmacist must forfeit the written prescription and take a new prescription verbally and reduce it to writing.

What type of container shall be used to transport radioactive materials? A. D.O.T Type 1B B. D.O.T Type 2A C. D.O.T Type 4C D. D.O.T Type 7A

(d) D.O.T Type 7A

All of the following functions are reported with Remote or Off-Site-Order Entry Pharmacy EXCEPT: A. Interpreting or clarifying prescription drug orders. B. Data entering of prescription drug order information. C. Performing Drug Regimen Review D. Dispensing of a prescription drug order.

(d) Dispensing of a prescription drug order, [Alabama Administrative Code 680-x-2-.39]. (a). Off-site order entry pharmacy means a non-hospital pharmacy which has a valid permit issued by the Board to process legend and controlled substance prescriptions that remotely accesses another pharmacy' electronic data base from outside the pharmacy in order to process prescription drug orders, provided the pharmacy establishes controls to protect the privacy and security of confidential records. (b). Off-site order entry does NOT include the dispensing of a prescription drug order but includes any of the following: 1. Interpreting or clarifying prescription drug orders; 2. Data entering and transferring of prescription drug order information 3. Performing drug regimen review; 4. Obtaining refill and substitution authorizations; 5. Performing therapeutic interventions; and 6. Providing clinical drug information concerning a patient' prescription. This rule does not apply to or allow any step of processing a prescription to be performed outside the physical premises of a pharmacy holding a permit with the Alabama State Board of Pharmacy. The following are expressly prohibited: (a). Work from home, work from call centers, and work from portable or hand held computers operated outside a location holding a permit with the Alabama State Board of Pharmacy. The Board of Pharmacy may at any time audit the records of any pharmacy holding a permit to ensure compliance with this provision.

In Alabama, how long is a CII prescription valid? A. 30 days from an issued date. B. 180 days from an issued date. C. 60 days from an issued date. D. None of the above

(d) None of the above, [http://www.albop.com/FAQ.aspx PRESCRIPTIONS: CONTROLLED SUBSTANCES Q.21]. A CII prescription does not have an expiration date in the state of Alabama. CIII through CIV prescriptions expire 6 months from the date written or after 5 refills (if permitted), whichever comes first. There are no written limits on CV prescriptions for time or refills.

After dispensing an emergency Schedule II drug, the pharmacist has to contact which of the following upon not receiving a written prescription from the prescriber within 7 days? I. The DEA Office II. The U.S. Department of Justice III. The State Pharmacy Board A. I only B. I and II only C. I and III only D. All

A. I only The DEA Office, [Code of Federal Regulation]. Nothing is specifically mentioned in Alabama Pharmacy Law about whom to contact when a pharmacist fails to receive an emergency CII prescription from the prescriber within 7 days. Therefore, we use the federal code regulation which mentions to contact the local DEA office. The pharmacist must, by regulation, notify the DEA diversion Office if the prescriber fails to provide the hard copy of the emergency dispensed medication within 7 days.

Any change in the control of ownership or licensed pharmacists shall be reported to the board in writing: A. within 10 days of such occurrence. B. within 20 days of such occurrence. C. within 15 days of such occurrence. D. Immediately.

A. within 10 days of such occurrence.

Which of the following is an appropriate steps to dispose of unused medicines through the household trash? [Select ALL That Apply]. A. Crush tablets or capsules to fine powder before mixing with an unpalatable substance. B. Mix medicines with an unpalatable substance such as dirt, kitty litter, or used coffee grounds. C. Place the mixture in a container and the container in a sealed plastic bag. D. Throw the container in the household trash.

B, C and D, [http://www.albop.com/FAQ.aspx Destruction of Unwanted Medications]. Many community-based drug "take-back" programs offer the best option for disposing household unused medicines. Few medicines may be especially harmful if taken by someone other than the person for whom the medicine was prescribed. Many of these medicines have specific disposal instructions on their labeling or patient's information leaflet. The following guidelines were developed to encourage the proper disposal of medicines and help reduce harm from accidental exposure or intentional misuse after they are no longer needed: 1. Follow any specific disposal instructions on the prescription drug labeling or patient information that accompanies the medicine. Do not flush medicine down the sink or toilet unless the medicine is in the list of FDA safe disposal. 2. Take advantage of programs that allow the public to take unused drugs to a central location for proper disposal. 3. Call the local law enforcement agencies about take back or contact the city or county government' household trash and recycling services to learn about medicine disposal options and guidelines for particular area. If there are no medicine take-back programs or DEA-authorized collectors available in a specific area, a patient can also follow these simple steps to dispose of most medicines through the household trash: 1. Mix medicines (do not crush tablets or capsules) with an unpalatable substance such as dirt, kitty litter, or used coffee grounds; 2. Place the mixture in a container and the container in a sealed plastic bag; 3. Throw the container in the household trash; 4. Scratch out all personal information on the prescription label of an empty pill bottle or empty medicine packaging to make it unreadable, and then dispose of the container through the household trash.

Which of the following groups of people should get vaccinated against hepatitis B? I. Sexually active people who are not in long-term, mutually monogamous relationships. II. Health care or public safety workers III. Everyone zero through 18 years of age. A. I only B. I and II only C. III only D. All

D. All

Which of the following is/are TRUE ABOUT internship hours under the Alabama State Pharmacy Law? I. The minimum externship/internship required for licensure shall be 1500 hours. II. 400 hours of the minimum total requirement may become attainable after completing the requirements of the second professional year. III. An extern/ intern must be employed a minimum of four (4) hours a week; however, no less than one (1) hour will be accepted for a particular day. A. I only B. I and II only C. II and III only D. All

D. All

In any Alabama resident pharmacy that is staffed by a single pharmacist, the pharmacist may leave the pharmacy area or department, temporarily, for breaks and meal periods without closing the pharmacy and removing interns/externs and technicians from the pharmacy. True or False

True In any Alabama resident pharmacy that is staffed by a single pharmacist, the pharmacist may leave the pharmacy area or department, temporarily, for breaks and meal periods without closing the pharmacy and removing interns/externs and technicians from the pharmacy, if the pharmacist reasonably believes that the security of the controlled substances will be maintained in his or her absence. During the pharmacist's temporary absence, no prescription medication may be provided to a patient or to a patient' agent unless the prescription medication is a new or refill medication that the pharmacist has checked, released for furnishing to the patient and was determined not to require the consultation of a pharmacist. During such times that the pharmacist is temporarily absent from the pharmacy area or department, the interns/externs and technicians may continue to perform the non-discretionary duties authorized to them by any applicable law or rule. However, any duty performed by an intern/extern or technician shall be reviewed by a pharmacist upon his or her return to the pharmacy. The temporary absence authorized by this rule shall be limited to thirty (30) minutes. The pharmacist shall remain within the facility during the break period and be available to handle all emergency situations.

Whenever there is a new supervising pharmacist, he/she shall be required to take an inventory of all controlled substances as defined in Title 20, Chapter 2, Code of Ala. 1975,

fifteen (15) days.